ProMIS Neurosciences
PMN
15 hedge funds and large institutions have $6.49M invested in ProMIS Neurosciences in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0.05% less ownership
Funds ownership: 1.19% → 1.14% (-0.05%)
17% less funds holding
Funds holding: 18 → 15 (-3)
30% less capital invested
Capital invested by funds: $9.24M → $6.49M (-$2.75M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Allostery Investments
Stamford,
Connecticut
|
+$32.8K |
| 2 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$4.25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$149K |
| 2 |
HCM
Heights Capital Management
San Francisco,
California
|
-$121K |
| 3 |
ABG
Ally Bridge Group
New York
|
-$91.6K |
| 4 |
HC
Hara Capital
Bellevue,
Washington
|
-$27.9K |
| 5 |
CAM
Claret Asset Management
Montreal,
Quebec, Canada
|
-$9.62K |
PMN Hedge Fund Activity: Q1 2025 in Review
15 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q1 2025, worth a combined $6.49M — down 30% from $9.24M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PMN and 0 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 2 added.
The largest buyer was Allostery Investments, adding an estimated $32.8K. The largest seller was Armistice Capital, cutting an estimated $149K.
- 15 institutional investors held ProMIS Neurosciences (PMN) as of Q1 2025, down from 18 in Q4 2024.
- Funds reported $6.49M of ProMIS Neurosciences stock for Q1 2025, down 30% quarter-over-quarter.
- 0 funds opened new ProMIS Neurosciences positions in Q1 2025 and 3 closed out, a net change of -3 holders.
- The largest ProMIS Neurosciences buyer in Q1 2025 was Allostery Investments, an estimated $32.8K added.
- The largest ProMIS Neurosciences seller in Q1 2025 was Armistice Capital, an estimated $149K sold.
Based on aggregated 13F filings for Q1 2025.